...Qiagen acquired bioinformatics company Ingenuity for $105 million in cash. Qiagen said the acquisition expands its... ...in biological data interpretation and creates value across its portfolio of sample and assay technologies. Ingenuity's... ...biological interactions from individually modeled relationships between proteins, genes, cells, tissues, metabolites, drugs and diseases. Ingenuity...
...On Dec. 26, 2012, Covidien said it will acquire cardiovascular company CV Ingenuity. The companies, which... ...The companies, which did not disclose details, expect the deal to close this quarter. CV Ingenuity... ...for vascular diseases, including treatment of peripheral artery disease (PAD) and prevention of restenosis. CV Ingenuity...
...Qiagen acquired bioinformatics company Ingenuity for $105 million in cash. Qiagen said the acquisition expands its... ...in biological data interpretation and creates value across its portfolio of sample and assay technologies. Ingenuity's... ...biological interactions from individually modeled relationships between proteins, genes, cells, tissues, metabolites, drugs and diseases. Ingenuity...
...On Dec. 26, 2012, Covidien said it will acquire cardiovascular company CV Ingenuity. The companies, which... ...The companies, which did not disclose details, expect the deal to close this quarter. CV Ingenuity... ...for vascular diseases, including treatment of peripheral artery disease (PAD) and prevention of restenosis. CV Ingenuity...